News tagged ‘LungCancer’ clear
- Dr. Pasi A. Jänne discusses a new study that demonstrates that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.
Tags: LungCancer, TargetedTherapy, Genetics
- Researchers, including Dr. Matthew Meyerson and Dr. Bruce Johnson of Dana-Farber, found from a large study of the genetics of a common lung cancer, that more than half the tumors from that cancer have mutations that can be treated by drugs that are being developed or can be easily developed. (Full article requires a subscription)
Tags: BasicResearch, LungCancer, Genetics
- Genetic testing can help clinicians assess a patient's risk for various diseases and to develop more effective treatment plans. Dana-Farber currently offers lung cancer patients six genetic tests and soon will test for more than 500 cancer-causing gene defects. As more genetic tests become available, some insurers and medical ethicists are questioning the value of such tests.
Tags: LungCancer, Genetics
- Dr. Deborah Schrag reported in the Journal of the American Medical Association that non-small cell lung cancer patients 65 years of age and older did not receive any survival benefit when Avastin was added to their standard chemotherapy. This finding counters an earlier study.
Tags: LungCancer
- Dr. Pasi Jänne and colleagues found that more than half of lung and colon cancer patients may benefit from high-speed tests that detect DNA flaws doctors can target with existing medicines.
Tags: ColonCancer, Genomics, LungCancer